F. Fernández-Cuenca

1000 total citations
11 papers, 812 citations indexed

About

F. Fernández-Cuenca is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, F. Fernández-Cuenca has authored 11 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Medicine, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in F. Fernández-Cuenca's work include Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Bacterial biofilms and quorum sensing (4 papers). F. Fernández-Cuenca is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Bacterial biofilms and quorum sensing (4 papers). F. Fernández-Cuenca collaborates with scholars based in Spain and United States. F. Fernández-Cuenca's co-authors include Álvaro Pascual, Jordi Vilà, Luis Martínez‐Martínez, Jesús Rodríguez‐Baño, Jerónimo Pachón, José Miguel Cisneros, Sara Martí, Germán Bou, Luis A. Actis and Sara M. Soto and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

F. Fernández-Cuenca

11 papers receiving 787 citations

Peers

F. Fernández-Cuenca
F. Fernández-Cuenca
Citations per year, relative to F. Fernández-Cuenca F. Fernández-Cuenca (= 1×) peers Esther Zander

Countries citing papers authored by F. Fernández-Cuenca

Since Specialization
Citations

This map shows the geographic impact of F. Fernández-Cuenca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Fernández-Cuenca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Fernández-Cuenca more than expected).

Fields of papers citing papers by F. Fernández-Cuenca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Fernández-Cuenca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Fernández-Cuenca. The network helps show where F. Fernández-Cuenca may publish in the future.

Co-authorship network of co-authors of F. Fernández-Cuenca

This figure shows the co-authorship network connecting the top 25 collaborators of F. Fernández-Cuenca. A scholar is included among the top collaborators of F. Fernández-Cuenca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Fernández-Cuenca. F. Fernández-Cuenca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
López, María, A. Rueda, Javier Pérez-Florido, et al.. (2016). Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010). Genome Announcements. 4(5). 4 indexed citations
2.
Rumbo, Carlos, Eva Gato, María López, et al.. (2013). Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 57(11). 5247–5257. 153 indexed citations
3.
Espinal, Paula, María D. Macià, Ignasi Roca, et al.. (2012). First Report of an OXA-23 Carbapenemase-Producing Acinetobacter baumannii Clinical Isolate Related to Tn 2006 in Spain. Antimicrobial Agents and Chemotherapy. 57(1). 589–591. 22 indexed citations
4.
Docobo-Pérez, Fernando, F. Fernández-Cuenca, María Eugenia Pachón-Ibáñez, et al.. (2008). Efficacy of amoxycillin–clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin. Clinical Microbiology and Infection. 14(6). 582–587. 2 indexed citations
5.
Rodríguez‐Baño, Jesús, Sara Martí, Sara M. Soto, et al.. (2008). Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clinical Microbiology and Infection. 14(3). 276–278. 217 indexed citations
6.
Beceiro, Alejandro, F. Fernández-Cuenca, Esteban Ribera, et al.. (2007). False extended-spectrum  -lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid. Journal of Antimicrobial Chemotherapy. 61(2). 301–308. 7 indexed citations
7.
Ruiz, María Teresa, Sara Martí, F. Fernández-Cuenca, Álvaro Pascual, & Jordi Vilà. (2007). High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clinical Microbiology and Infection. 13(12). 1192–1198. 69 indexed citations
8.
Fernández-Cuenca, F., José Manuel Rodríguez-Martínez, Luis Martínez‐Martínez, & Álvaro Pascual. (2006). In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40kDa outer membrane protein and hyperproduction of AmpC β-lactamase. International Journal of Antimicrobial Agents. 27(6). 549–552. 28 indexed citations
9.
Cisneros, José Miguel, Jesús Rodríguez‐Baño, F. Fernández-Cuenca, et al.. (2005). Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clinical Microbiology and Infection. 11(11). 874–879. 101 indexed citations
10.
Ribera, Esteban, F. Fernández-Cuenca, Alejandro Beceiro, et al.. (2004). Antimicrobial Susceptibility and Mechanisms of Resistance to Quinolones and β-Lactams in Acinetobacter Genospecies 3. Antimicrobial Agents and Chemotherapy. 48(4). 1430–1432. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026